CONSENT AGREEMENT BETWEEN - State Medical Board of Ohio ...

Matter of Kyle Elliott Hoogendoorn, D.P.M. Page 28
Testimony of Dr. Griffin
62. Dr. Griffin testified that Dr. Hoogendoorn had joined the fellowship when Dr. Griffin was a
second-year fellow. Dr. Griffin testified that Dr. Leak had asked him, as a second-year
fellow, to supervise and teach Dr. Hoogendoorn about pain medicine. Dr. Griffin noted
that he had been aware that Dr. Hoogendoorn was a podiatrist. (Tr. at 3005-3007)
Dr. Griffin testified that he had supervised Dr. Hoogendoorn’s performance of procedures
because Dr. Hoogendoorn had been a fellow and was there to learn about pain medicine.
Dr. Griffin further testified that he had done so based on “many, many discussions with
Dr. Leak[,]” whom Dr. Griffin testified “ran a pretty tight ship.” (Tr. at 647-648,
3006-3008)
Dr. Griffin added: “We were trying to teach him about pain management, [the]
pharmacological side, and the interventional side as far as he could take it, with the idea that
it was his choice as to how to implement that into a podiatry practice.” (Tr. at 815-816)
Testimony of Dr. Hoogendoorn
63. Dr. Hoogendoorn testified that he had believed that the procedures he performed that were
beyond his podiatric scope of practice had been performed under the scope of practice of
the attending physician. Dr. Hoogendoorn further testified that he had recognized both
Dr. Leak and Dr. Griffin as his attending physicians. (Tr. at 278)
Dr. Hoogendoorn further testified that every podiatric residency program in Ohio and in the
country includes rotations through services that would be beyond the scope of podiatry,
such as surgery, general medicine, and anesthesiology. Dr. Hoogendoorn added that
residents in these programs are not just permitted but are required to scrub in on surgeries
for non-podiatric conditions. Dr. Hoogendoorn testified that, although podiatrists’
practices are limited in scope, they need to become familiar with the body as a whole to
recognize non-podiatric conditions that their patients may suffer from. (Tr. at 281-287)
64. Dr. Hoogendoorn testified as follows concerning the training he received at PCC prior to
being allowed to perform injection procedures:
During that first period of several months of shadowing and even before—
even after that, before any invasive procedure was ever done, whether a
trigger point or chemoneurolytic injection, the attending would show me
exactly how to do it; what we would have to know; what he would expect me
to know; what medications were going in; why we were using those; why we
were using certain local anesthetics versus others; if we’re adding anything to
it, like a steroid, why that was being done; placement, choice of placement